IHE
ETF
Pharmaceuticals
NYSEARCA
iShares U.S. Pharmaceuticals ETF
$90.42
+0.32 (+0.36%)
Fund Overview
by iShares (BlackRock)
Pure pharmaceutical exposure focused on drug manufacturers. Excludes biotech and medical device companies for a cleaner pharma play. Equal-weighted methodology gives mid-cap pharma companies more influence.
AUM$680M
Expense Ratio0.40%
Holdings42
Dividend Yield1.4%
DistributionQuarterly
BenchmarkDow Jones U.S. Select Pharmaceuticals Index
InceptionMay 2006
ExchangeNYSEARCA
Price Data
Open$90.46
Prev Close$90.10
Day Range$90.24 — $91.49
Investment Calculator
See how much dividend income IHE could generate based on its current price of $90.42 and 1.4% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,946.20
Annual Income$139.25
Monthly Income$11.60
Based on current dividend yield of 1.4%. Actual distributions may vary. Past dividends do not guarantee future payments.
Pharmaceuticals ETF Comparison
| ETF | Price | Change | Expense | AUM | Holdings | Yield |
|---|---|---|---|---|---|---|
| IHE | $90.42 | +0.36% | 0.40% | $680M | 42 | 1.4% |
| PPH | $111.19 | +0.81% | 0.36% | $540M | 25 | 1.8% |
Top Pharmaceuticals Stocks
View all →
IHE FAQ
What is IHE?
IHE is the iShares U.S. Pharmaceuticals ETF, an exchange-traded fund managed by iShares (BlackRock). It tracks the Dow Jones U.S. Select Pharmaceuticals Index and holds 42 Pharmaceuticals securities with an expense ratio of 0.40%.
What is the expense ratio of IHE?
IHE charges an annual expense ratio of 0.40%, which means you pay $40.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does IHE pay dividends?
Yes, IHE pays a 1.4% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $140.00 per year in dividend income.
What are the alternatives to IHE?
Other pharmaceuticals ETFs include PPH. Each offers different expense ratios, weighting methodologies, and number of holdings. Compare them in the ETF comparison table above to find the best fit for your portfolio.
Explore Pharmaceuticals Stocks
View our full list of individual pharmaceuticals stocks with prices, fundamentals, and analyst ratings.
Last updated: Feb 15, 2026 at 1:14 AM ET